Medical News

RSS

Sleep may hold the key to staying active

Getting enough sleep and staying active are two of the most important things we can do for our health, but new research shows that most people struggle to achieve both, and that sleep may hold the key to moving more.

8 Dec 2025

Receiving immunotherapy earlier in the day may improve survival in cancer patients

Receiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That's according to a study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

8 Dec 2025

New combination treatment offers significant benefits for people with recurring grade 3 astrocytoma

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an aggressive form of brain cancer, live longer.

8 Dec 2025

Integrating AI into colon cancer diagnosis improves the speed and accuracy of detection

A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has significantly improved the speed and accuracy of the detection of the deadly disease.

8 Dec 2025

Blood sugar migration to saliva fuels cavity development in type 2 diabetes patients

Individuals with type 2 diabetes often have a higher incidence of tooth decay, but the underlying mechanisms remain unclear.

8 Dec 2025

Lab Thread announces beta release of unified lab software platform

Lab Thread Ltd, a UK-based life science software company, today announced the beta launch of its flagship unified lab software platform.

8 Dec 2025

Standard UK road crossing times may be unrealistic for older people with limited mobility

Road crossings need to slow down to allow people with mobility issues and older pedestrians enough time to use them, research has indicated.

8 Dec 2025

A North Carolina hospital was slated to open in 2025. Mired in bureaucracy, it’s still a dirt field.

Madison County, tucked in the mountains of western North Carolina, has no hospital and just three ambulances serving its roughly 22,000 people.

8 Dec 2025

Social media affects children's ability to concentrate, study reveals

Children who spend a significant amount of time on social media tend to experience a gradual decline in their ability to concentrate.

8 Dec 2025

Lower dose of immunotherapy for malignant melanoma improves results

According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects.

8 Dec 2025

Study reveals the hidden toll of sudden cardiac death in type 1 and type 2 diabetes

A Danish nationwide study found that people with type 1 and type 2 diabetes have markedly higher rates of sudden cardiac death than the general population, especially at younger ages. At age 30, people with diabetes lose many years of life, with several of those years specifically attributable to sudden cardiac death.

7 Dec 2025

Noninvasive Raman device tracks blood glucose accurately in under a minute

MIT researchers developed a compact band-pass Raman spectroscopy device that noninvasively tracks glucose through the skin in under a minute using physically interpretable optical signals. In a pilot study and tissue phantom validation, the system showed glucose measurements comparable to commercial continuous glucose monitors, supporting further clinical evaluation.

7 Dec 2025

Young Australians are staying on antidepressants for longer than ever

Long-term antidepressant use in Australia increased steadily between 2014 and 2023, with the largest relative rise seen among adolescents and young adults aged 10 to 24 years. Treatment duration also lengthened over time, while apparent dose reduction efforts remained limited, raising concerns about deprescribing practices.

7 Dec 2025

Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study.

7 Dec 2025

Virtual diet and exercise program shows promise in reducing lymphoma treatment side effects

Patients undergoing treatment for lymphoma often experience adverse side effects that can be so severe that they stop or slow treatment.

7 Dec 2025

Kiwifruit intake boosts vitamin C in skin and supports dermal structure

Study shows that increasing dietary vitamin C intake with kiwifruit raises vitamin C levels in both the dermis and epidermis through active transport from the bloodstream. Higher skin vitamin C levels were associated with increased skin density and epidermal cell proliferation, but not with improved UV protection or measurable increases in new collagen markers.

7 Dec 2025

Shingles vaccination is linked to fewer dementia diagnoses and deaths in older adults

A large quasi-experimental study in Wales shows that eligibility for shingles vaccination is linked to fewer new mild cognitive impairment diagnoses and lower dementia-related mortality. Benefits appear strongest in women and are observed at multiple stages of the dementia disease course.

7 Dec 2025

Evidence grows for pirtobrutinib as a safer and effective alternative for CLL and SLL

Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms of overall response rate in the first head-to-head comparison with ibrutinib, a covalent BTK inhibitor.

7 Dec 2025

Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction chemotherapy.

7 Dec 2025

New trial shows major survival gains with epcoritamab added to standard R2 therapy

In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab in addition to the standard second-line regimen versus the standard regimen alone.

7 Dec 2025

Previous
1
...
5
6
7
8
9
10
11
...
17763
Next

Medical News

Sleep may hold the key to staying active

Receiving immunotherapy earlier in the day may improve survival in cancer patients

New combination treatment offers significant benefits for people with recurring grade 3 astrocytoma

Integrating AI into colon cancer diagnosis improves the speed and accuracy of detection

Blood sugar migration to saliva fuels cavity development in type 2 diabetes patients

Lab Thread announces beta release of unified lab software platform

Standard UK road crossing times may be unrealistic for older people with limited mobility

A North Carolina hospital was slated to open in 2025. Mired in bureaucracy, it’s still a dirt field.

Social media affects children's ability to concentrate, study reveals

Lower dose of immunotherapy for malignant melanoma improves results

Study reveals the hidden toll of sudden cardiac death in type 1 and type 2 diabetes

Noninvasive Raman device tracks blood glucose accurately in under a minute

Young Australians are staying on antidepressants for longer than ever

Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL

Virtual diet and exercise program shows promise in reducing lymphoma treatment side effects

Kiwifruit intake boosts vitamin C in skin and supports dermal structure

Shingles vaccination is linked to fewer dementia diagnoses and deaths in older adults

Evidence grows for pirtobrutinib as a safer and effective alternative for CLL and SLL

Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients

New trial shows major survival gains with epcoritamab added to standard R2 therapy

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News